Digital Health and Pharmacovigilance: An Unlikely Partnership?

Sponsored by: Cognizant
Speakers:

Bryan Hill, Chief Technology Officer and Vice President & Innovation for Life Sciences, Cognizant
Vidya Viswanathan, Digital Health Show Runner and Solution Leader, Life Sciences, Cognizant
A representative from AbbVie will also be part of the panel

Tuesday - October 19, 2021 / 11am ET
Free Event

Register now

Digital health connects people to their health status and healthcare by promoting decision-making, empathetic care delivery, and overall health and wellness awareness, while the pharmacovigilance function collects, analyzes, reports, and seeks to minimize adverse drug events. Arguably the two seem like unlikely partners. In reality, their intersection can form a yin and yang partnership – both aim to optimize the safe and effective use of medicinal therapies through solutions that minimize risks and amplify benefits.

The Benefit Risk Management (BRM) group within AbbVie’s pharmacovigilance organization studies the benefits and risks of new medicinal products during their development and formulates ideas around what, why and how patients and their healthcare providers need to be supported during the care delivery process. AbbVie has worked with Cognizant’s Life Sciences digital innovators to find ways to move these ideas into digital health solutions geared to minimize risks, enable end-to-end care management, and connect patients and providers.

During this virtual discussion, the speakers will talk about this new paradigm, called Digital Risk Minimization, and how it could foster a new foundational dimension to digital health. They will discuss how the unlikely partners of digital health and pharmacovigilance can become pioneers in a quest to define and promote a new opportunity to leverage digital technology for risk minimization.

Key takeaways:

  • Digital health strategy must begin within R&D; the vision of unified patient experience through the value chain can be realized through this approach
  • You can reimagine safety as the patient advocate
  • Digital health ROI and value amplifies and propagates to clinical and commercial through early investments

About the Sponsors

Cognizant is one of the world's leading professional services companies, transforming clients' business, operating and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Cognizant is ranked 185 on the Fortune 500 and consistently listed among the world’s most admired companies.

For more information please visit www.cognizant.com/.

Posted in: Phamacovigilance

Comments are closed.

FEEDBACK